Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fresenius SE & Co. KGaA - SIC # 8620 -
Ticker
Exchange
SIC #
Website
Latest Ticker
FSNUY
Over the counter
8620
www.fresenius.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fresenius SE & Co. KGaA
Tandem Diabetes Care (TNDM) Down 9.2% Since Last Earnings Report: Can It Rebound?
- Dec 6th, 2024 4:31 pm
Here's Why Fresenius (FMS) is a Strong Value Stock
- Dec 3rd, 2024 2:40 pm
Formycon AG (XTER:FYB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges
- Nov 29th, 2024 7:01 am
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
- Nov 14th, 2024 2:40 pm
Fresenius SE KGaA Third Quarter 2024 Earnings: Beats Expectations
- Nov 12th, 2024 4:33 am
Humacyte Inc (HUMA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
- Nov 9th, 2024 7:06 am
Fresenius SE & Co KGaA (FSNUF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
- Nov 7th, 2024 7:05 am
Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?
- Nov 6th, 2024 2:50 pm
Fresenius SE Raises Guidance After Strong Kabi, Helios Performances
- Nov 6th, 2024 8:16 am
Stocks to watch this week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
- Nov 1st, 2024 4:24 pm
Fresenius SE KGaA's (ETR:FRE) investors will be pleased with their respectable 41% return over the last year
- Oct 30th, 2024 10:13 am
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?
- Oct 28th, 2024 1:40 pm
Fresenius Kabi and Cellular Origins agree CGT manufacture automation
- Oct 17th, 2024 2:12 pm
Is Fresenius SE & Co. (FSNUY) Stock Undervalued Right Now?
- Oct 10th, 2024 1:40 pm
Fresenius SE & Co KGaA (FSNUF) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
- Oct 9th, 2024 7:29 pm
Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage
- Oct 9th, 2024 6:24 pm
Fresenius looking to boost output after hurricane damage at rival Baxter
- Oct 8th, 2024 1:11 pm
While institutions own 30% of Fresenius SE & Co. KGaA (ETR:FRE), individual investors are its largest shareholders with 43% ownership
- Oct 7th, 2024 6:58 am
Here's Why Fresenius (FMS) is a Strong Momentum Stock
- Oct 4th, 2024 1:50 pm
Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi
- Oct 1st, 2024 2:53 pm
Scroll